{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T23:00:33Z","timestamp":1789426833067,"version":"build-2803163510"},"reference-count":46,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T00:00:00Z","timestamp":1576195200000},"content-version":"vor","delay-in-days":1991,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100005940","name":"Danish Cancer Research Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005940","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Molecular Diagnostics"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.jmoldx.2014.03.002","type":"journal-article","created":{"date-parts":[[2014,6,6]],"date-time":"2014-06-06T05:15:46Z","timestamp":1402031746000},"page":"418-430","source":"Crossref","is-referenced-by-count":57,"title":["Diagnostic Potential of miR-126, miR-143, miR-145, and miR-652 in Malignant Pleural Mesothelioma"],"prefix":"10.1016","volume":"16","author":[{"given":"Morten","family":"Andersen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten","family":"Grauslund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesper","family":"Ravn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens B.","family":"S\u00f8rensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus B.","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Santoni-Rugiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmoldx.2014.03.002_bib1","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.currproblcancer.2004.04.001","article-title":"Malignant pleural mesothelioma","volume":"28","author":"Pass","year":"2004","journal-title":"Curr Probl Cancer"},{"key":"10.1016\/j.jmoldx.2014.03.002_bib2","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0140-6736(05)67025-0","article-title":"Malignant mesothelioma","volume":"366","author":"Robinson","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jmoldx.2014.03.002_bib3","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1183\/09031936.00063109","article-title":"Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma","volume":"35","author":"Scherpereel","year":"2010","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jmoldx.2014.03.002_bib4","doi-asserted-by":"crossref","first-page":"647","DOI":"10.5858\/arpa.2012-0214-OA","article-title":"Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group","volume":"137","author":"Husain","year":"2013","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jmoldx.2014.03.002_bib5","doi-asserted-by":"crossref","first-page":"E96","DOI":"10.1111\/j.1365-2559.2012.04196.x","article-title":"The diagnostic value of immunohistochemically detected methylthioadenosine phosphorylase deficiency in malignant pleural mesotheliomas","volume":"60","author":"Zimling","year":"2012","journal-title":"Histopathology"},{"key":"10.1016\/j.jmoldx.2014.03.002_bib6","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1097\/PAS.0b013e318218985b","article-title":"Oncofetal protein IMP3, a new diagnostic biomarker to distinguish malignant mesothelioma from reactive mesothelial proliferation","volume":"35","author":"Shi","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jmoldx.2014.03.002_bib7","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","article-title":"MicroRNAs: target recognition and regulatory functions","volume":"136","author":"Bartel","year":"2009","journal-title":"Cell"},{"issue":"Database issue","key":"10.1016\/j.jmoldx.2014.03.002_bib8","doi-asserted-by":"crossref","first-page":"D140","DOI":"10.1093\/nar\/gkj112","article-title":"miRBase: microRNA sequences, targets and gene nomenclature","volume":"34","author":"Griffiths-Jones","year":"2006","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jmoldx.2014.03.002_bib9","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1101\/gr.082701.108","article-title":"Most mammalian mRNAs are conserved targets of microRNAs","volume":"19","author":"Friedman","year":"2009","journal-title":"Genome Res"},{"key":"10.1016\/j.jmoldx.2014.03.002_bib10","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.molonc.2012.09.006","article-title":"MicroRNA and cancer","volume":"6","author":"Jansson","year":"2012","journal-title":"Mol Oncol"},{"key":"10.1016\/j.jmoldx.2014.03.002_bib11","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1152\/physrev.00006.2010","article-title":"MicroRNAs in development and disease","volume":"91","author":"Sayed","year":"2011","journal-title":"Physiol Rev"},{"key":"10.1016\/j.jmoldx.2014.03.002_bib12","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1136\/jcp.2008.058339","article-title":"Tissues from routine pathology archives are suitable for microRNA analyses by quantitative PCR","volume":"62","author":"Siebolts","year":"2009","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.jmoldx.2014.03.002_bib13","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1073\/pnas.0510565103","article-title":"A microRNA expression signature of human solid tumors defines cancer gene targets","volume":"103","author":"Volinia","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jmoldx.2014.03.002_bib14","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/nature03702","article-title":"MicroRNA expression profiles classify human cancers","volume":"435","author":"Lu","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.jmoldx.2014.03.002_bib15","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ccr.2007.12.008","article-title":"MicroRNA signature predicts survival and relapse in lung cancer","volume":"13","author":"Yu","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jmoldx.2014.03.002_bib16","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ccr.2006.01.025","article-title":"Unique microRNA molecular profiles in lung cancer diagnosis and prognosis","volume":"9","author":"Yanaihara","year":"2006","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jmoldx.2014.03.002_bib17","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1165\/rcmb.2009-0060OC","article-title":"MicroRNA signature of malignant mesothelioma with potential diagnostic and prognostic implications","volume":"42","author":"Busacca","year":"2010","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.jmoldx.2014.03.002_bib18","doi-asserted-by":"crossref","first-page":"771","DOI":"10.2353\/jmoldx.2010.090169","article-title":"A diagnostic assay based on microRNA expression accurately identifies malignant pleural mesothelioma","volume":"12","author":"Benjamin","year":"2010","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.jmoldx.2014.03.002_bib19","doi-asserted-by":"crossref","first-page":"e18232","DOI":"10.1371\/journal.pone.0018232","article-title":"Association of MiR-126 with soluble mesothelin-related peptides, a marker for malignant mesothelioma","volume":"6","author":"Santarelli","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jmoldx.2014.03.002_bib20","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1002\/ijc.25285","article-title":"Downregulated microRNAs in the differential diagnosis of malignant pleural mesothelioma","volume":"127","author":"Gee","year":"2010","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jmoldx.2014.03.002_bib21","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/gcc.20669","article-title":"CDKN2A, NF2, and JUN are dysregulated among other genes by miRNAs in malignant mesothelioma -A miRNA microarray analysis","volume":"48","author":"Guled","year":"2009","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.jmoldx.2014.03.002_bib22","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1097\/JTO.0b013e31820db125","article-title":"MicroRNAs dysregulation in human malignant pleural mesothelioma","volume":"6","author":"Balatti","year":"2011","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jmoldx.2014.03.002_bib23","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1097\/JTO.0b013e3182572e83","article-title":"Increased circulating miR-625-3p: a potential biomarker for patients with malignant pleural mesothelioma","volume":"7","author":"Kirschner","year":"2012","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jmoldx.2014.03.002_bib24","doi-asserted-by":"crossref","first-page":"e30221","DOI":"10.1371\/journal.pone.0030221","article-title":"Identification of miRNA-103 in the cellular fraction of human peripheral blood as a potential biomarker for malignant mesothelioma\u2013a pilot study","volume":"7","author":"Weber","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jmoldx.2014.03.002_bib25","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.clinbiochem.2012.02.009","article-title":"Clinical significance of circulating miR-126 quantification in malignant mesothelioma patients","volume":"45","author":"Tomasetti","year":"2012","journal-title":"Clin Biochem"},{"key":"10.1016\/j.jmoldx.2014.03.002_bib26","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/j.1600-0463.2012.02891.x","article-title":"Are differentially expressed microRNAs useful in the diagnostics of malignant pleural mesothelioma?","volume":"120","author":"Andersen","year":"2012","journal-title":"APMIS"},{"key":"10.1016\/j.jmoldx.2014.03.002_bib27","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative C(T) method","volume":"3","author":"Schmittgen","year":"2008","journal-title":"Nat Protoc"},{"key":"10.1016\/j.jmoldx.2014.03.002_bib28","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1056\/NEJMoa060570","article-title":"DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy","volume":"355","author":"Olaussen","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jmoldx.2014.03.002_bib29","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1093\/annonc\/mdq053","article-title":"ERCC1 and histopathology in advanced NSCLC patients randomized in a large multicenter phase III trial","volume":"21","author":"Vilmar","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jmoldx.2014.03.002_bib30","doi-asserted-by":"crossref","first-page":"5205","DOI":"10.1158\/1078-0432.CCR-11-0658","article-title":"Class III \u03b2-tubulin in advanced NSCLC of adenocarcinoma subtype predicts superior outcome in a randomized trial","volume":"17","author":"Vilmar","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jmoldx.2014.03.002_bib31","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/JTO.0b013e318233d6a9","article-title":"Low ERCC1 expression in malignant pleural mesotheliomas treated with cisplatin and vinorelbine predicts prolonged progression-free survival","volume":"7","author":"Zimling","year":"2012","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jmoldx.2014.03.002_bib32","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s00280-012-1965-0","article-title":"A biomarker profile for predicting efficacy of cisplatin-vinorelbine therapy in malignant pleural mesothelioma","volume":"70","author":"Zimling","year":"2012","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.jmoldx.2014.03.002_bib33","series-title":"Practical Statistics for Medical Research","first-page":"351","author":"Altman","year":"1991"},{"key":"10.1016\/j.jmoldx.2014.03.002_bib34","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/onc.2012.28","article-title":"Loss of microRNA-143\/145 disturbs cellular growth and apoptosis of human epithelial cancers by impairing the MDM2-p53 feedback loop","volume":"32","author":"Zhang","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.jmoldx.2014.03.002_bib35","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1002\/ijc.24827","article-title":"Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma","volume":"126","author":"Schaefer","year":"2010","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jmoldx.2014.03.002_bib36","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/01.ede.0000147512.81966.ba","article-title":"Optimal cut-point and its corresponding Youden Index to discriminate individuals using pooled blood samples","volume":"16","author":"Schisterman","year":"2005","journal-title":"Epidemiology"},{"key":"10.1016\/j.jmoldx.2014.03.002_bib37","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.febslet.2011.03.039","article-title":"miR-126 inhibits proliferation of small cell lung cancer cells by targeting SLC7A5","volume":"585","author":"Miko","year":"2011","journal-title":"FEBS Lett"},{"key":"10.1016\/j.jmoldx.2014.03.002_bib38","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.bbrc.2008.06.090","article-title":"MicroRNA-126 inhibits invasion in non-small cell lung carcinoma cell lines","volume":"373","author":"Crawford","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jmoldx.2014.03.002_bib39","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1177\/1947601912458687","article-title":"Roles for crk in cancer metastasis and invasion","volume":"3","author":"Tsuda","year":"2012","journal-title":"Genes Cancer"},{"key":"10.1016\/j.jmoldx.2014.03.002_bib40","first-page":"4075","article-title":"L-type amino acid transporter 1 (LAT1) expression in malignant pleural mesothelioma","volume":"31","author":"Kaira","year":"2011","journal-title":"Anticancer Res"},{"key":"10.1016\/j.jmoldx.2014.03.002_bib41","doi-asserted-by":"crossref","first-page":"732690","DOI":"10.1155\/2011\/732690","article-title":"Identification of differentially expressed microRNAs in osteosarcoma","volume":"2011","author":"Lulla","year":"2011","journal-title":"Sarcoma"},{"key":"10.1016\/j.jmoldx.2014.03.002_bib42","doi-asserted-by":"crossref","first-page":"4919","DOI":"10.1158\/1078-0432.CCR-12-0016","article-title":"The rectal cancer microRNAome\u2013microRNA expression in rectal cancer and matched normal mucosa","volume":"18","author":"Gaedcke","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jmoldx.2014.03.002_bib43","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/1756-9966-29-151","article-title":"miRNA-145 inhibits non-small cell lung cancer cell proliferation by targeting c-Myc","volume":"29","author":"Chen","year":"2010","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.jmoldx.2014.03.002_bib44","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.yexcr.2010.11.010","article-title":"Regulation of microRNA-145 by growth arrest and differentiation","volume":"317","author":"La Rocca","year":"2011","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.jmoldx.2014.03.002_bib45","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/jcp.21796","article-title":"Mechanism of growth inhibition by MicroRNA 145: the role of the IGF-I receptor signaling pathway","volume":"220","author":"La Rocca","year":"2009","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.jmoldx.2014.03.002_bib46","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/bjc.2012.510","article-title":"Mir143 expression inversely correlates with nuclear ERK5 immunoreactivity in clinical prostate cancer","volume":"108","author":"Ahmad","year":"2013","journal-title":"Br J Cancer"}],"container-title":["The Journal of Molecular Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152515781400066X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152515781400066X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T10:38:26Z","timestamp":1716806306000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152515781400066X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S152515781400066X"],"URL":"https:\/\/doi.org\/10.1016\/j.jmoldx.2014.03.002","relation":{},"ISSN":["1525-1578"],"issn-type":[{"value":"1525-1578","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]}}}